id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2022-0026-0101,DEA,DEA-2022-0026,"Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I; Withdrawal",Proposed Rule,,2022-08-29T04:00:00Z,2022,8,2022-08-29T04:00:00Z,,2022-08-29T12:38:14Z,2022-18729,0,0,09000064852853f2
DEA-2022-0026-0003,DEA,DEA-2022-0026,DEA824 DEA 8-factor_DOIandDOC_DOE_082021,Supporting & Related Material,,2022-04-11T04:00:00Z,2022,4,,,2022-04-11T14:27:34Z,,0,0,090000648500b68f
DEA-2022-0026-0002,DEA,DEA-2022-0026,FINAL SIGNED ASH Letter to DEA_DOI-DOC_09.28.2020,Supporting & Related Material,,2022-04-11T04:00:00Z,2022,4,,,2022-04-11T14:27:28Z,,0,0,090000648500b69e
DEA-2022-0026-0001,DEA,DEA-2022-0026,"Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I",Proposed Rule,,2022-04-11T04:00:00Z,2022,4,2022-04-11T04:00:00Z,2022-06-11T03:59:59Z,2022-06-12T00:21:41Z,2022-07648,0,0,090000648500addc